Twelve weeks supplementation with an extended-release caffeine and ATP-enhancing supplement may improve body composition without affecting hematology in resistance-trained men

Table 3 Vital Signs and Blood Lipid Data

Variable	Treatment	PRE	Week 8	POST	Reference Interval	p
Systolic BP (mm Hg)	PLA	127 ± 12.0	126.0 ± 12.2	127.0 ± 12.2	90–120	0.93
Systolic BP (mm Hg)	TRT	127.6 ± 12.8	127.7 ± 8.7	128.0 ± 10.4	90–120	0.93
Diastolic BP (mm Hg)	PLA	76.1 ± 9.4	77.0 ± 8.0	76.4 ± 9.4	60–80	0.20
Diastolic BP (mm Hg)	TRT	76.6 ± 8.1	74.2 ± 9.4	78.2 ± 8.6	60–80	0.20
Heart Rate (BPM)	PLA	68.9 ± 10.6	70.1 ± 10.1	70.0 ± 7.7	<100	0.43
Heart Rate (BPM)	TRT	58.9 ± 12.0	62.1 ± 9.7	64.9 ± 9.4	<100	0.43
Total Cholesterol (mg/dL)	PLA	175.9 ± 41.9	175.1 ± 43.2	172.8 ± 41.0	100–199	0.39
Total Cholesterol (mg/dL)	TRT	161.2 ± 19.4	173.1 ± 22.3	164.2 ± 29.3	100–199	0.39
Triglycerides (mg/dL)	PLA	109.7 ± 53.0	81.4 ± 37.9	89.5 ± 33.3	0–149	0.055
Triglycerides (mg/dL)	TRT	65.9 ± 22.2	74.5 ± 33.4	69.3 ± 36.5	0–149	0.055
High Density Lipoprotein (mg/dL)	PLA	50.1 ± 13.3	47.6 ± 12.6	48.5 ± 11.2	>39	0.38
High Density Lipoprotein (mg/dL)	TRT	53.8 ± 6.4	54.2 ± 10.2	50.8 ± 8.2	>39	0.38
Very Low Density Lipoprotein (mg/dL)	PLA	21.9 ± 10.5	16.3 ± 7.6	18.0 ± 6.8	5–40	0.06
Very Low Density Lipoprotein (mg/dL)	TRT	13.3 ± 4.5	15.0 ± 6.8	13.8 ± 7.3	5–40	0.06
Low Density Lipoprotein (mg/dL)	PLA	103.9 ± 31.7	111.2 ± 31.2	106.4 ± 31.0	0–99	0.89
Low Density Lipoprotein (mg/dL)	TRT	94.1 ± 18.8	103.9 ± 19.9	99.7 ± 24.4	0–99	0.89

Data are presented as mean ± standard deviation. The p-value is derived from an ANOVA and representative of a main effect for group by time

ISSN: 1550-2783